The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-15 of 15 articles
Clinical outcomes with unselected use of an ultrathin-strut sirolimus-eluting stent: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
Buccheri S,
Sarno G,
Erlinge D,
Renlund H,
Lagerqvist B,
Grimfjärd P,
Witt N,
Yndigegn T,
Fröbert O,
Persson J,
Böhm F,
James S
April 20, 2021 | 10.4244/EIJ-D-20-00429
Clinical outcome after interventions with paclitaxel-coated balloons: a PCR statement
Lansky AJ,
Cremonesi A,
Scheller B,
James S,
Grubman D,
Fajadet J,
Sauguet A,
Micari A,
Sarno G,
Bosiers M,
Baumbach A,
Wijns W
February 20, 2020 | 10.4244/EIJV15I14A220
Bioabsorbable polymer everolimus-eluting stents in patients with acute myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry
Buccheri S,
Sarno G,
Lagerqvist B,
Olivecrona G,
Hambraeus K,
Witt N,
Lindholm D,
Erlinge D,
Angeras O,
James S
August 3, 2018 | 10.4244/EIJ-D-18-00392
A novel dedicated 3-dimensional quantitative coronary analysis methodology for bifurcation lesions
September 30, 2011 | 10.4244/EIJV7I5A100
Intravascular ultrasound radiofrequency analysis after optimal coronary stenting with initial quantitative coronary angiography guidance: an ATHEROREMO sub-study
Sarno G,
Garg S,
Gomez-Lara J,
Garcia-Garcia HM,
Ligthart J,
Bruining N,
Onuma Y,
Witberg K,
van Geuns R,
de Boer S,
Wykrzykowska JJ,
Schultz C,
Duckers H,
Regar E,
de Jaegere P,
de Feyter P,
Van Es G-A,
Boersma E,
van der Giessen WJ,
Serruys P
March 21, 2011
The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer
Garg S,
Sarno G,
Serruys P,
de Vries T,
Buszman P,
Linke A,
Ischinger T,
Klauss V,
Eberli F,
Corti R,
Wijns W,
Morice M,
Di Mario C,
van Geuns R,
Eerdmans P,
Van Es G-A,
Meier B,
Jüni P,
Windecker S
June 30, 2010
How should I treat a complex Post-CABG patient?
November 15, 2009 | 10.4244/EIJV5I5A100
The ProLimus trial: a prospective, non-randomised, multicentre trial to evaluate the safety and clinical performance of the pimecrolimus eluting stent system (ProGenic)
Verheye S,
Sarno G,
Muller R,
Birkemeyer R,
Vrints C,
Jung W,
Agostoni P,
van Langenhove G,
Haine S,
Willems T,
Haude M,
Grube E,
Wijns W
June 30, 2009 | 10.4244/EIJV5I2A36
Latest news
AHEAD OF PRINT
Ticagrelor monotherapy in PCI patients with prior CABG: the TWILIGHT-CABG study
FREE ARTICLE - Gennaro Sardella et al
August 18, 2022
AHEAD OF PRINT
First-in-human implantation of the Topaz transcatheter tricuspid valve replacement system
FREE ARTICLE - Emmanuel Teiger et al
August 16, 2022
AHEAD OF PRINT
Extracardiac basal annuloplasty for the treatment of secondary mitral regurgitation
FREE ARTICLE - Jérémy Bernard et al
August 11, 2022
NEW ISSUE
The 16th EBC Expert consensus; ticagrelor or aspirin monotherapy 1 year after PCI; vasospasm and atherosclerosis in ANOCA; lifetime valve journey; and more…
August 5, 2022
AHEAD OF PRINT
LVOT calcification in TAVI : a post hoc analysis from the SOLVE-TAVI trial
FREE ARTICLE - Serdar Farhan et al
August 9, 2022
AHEAD OF PRINT
RADIANCE-HTN SOLO 36-month analysis
FREE ARTICLE - Florian Rader et al
August 1, 2022
AHEAD OF PRINT
Percutaneous left atrial appendage closure with superior vascular access
FREE ARTICLE - Roberto Galea et al
August 4, 2022